Trials / Completed
CompletedNCT00663559
Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy
Study Phase II to Determinate the Efficacy of Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Spanish Oncology Genito-Urinary Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determinate the efficacy of Sunitinib in patients with renal cells carcinoma metastasic or locally avanced in patints not candidates to inicial curative nefrectomy.
Detailed description
Study phase II in with one arm in patients with renal cells carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sunitinib | Sunitinib 50mg oral in the morning during 4 weeks with 2 weeks of break. |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-08-01
- Completion
- 2010-02-01
- First posted
- 2008-04-22
- Last updated
- 2014-12-18
Locations
7 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT00663559. Inclusion in this directory is not an endorsement.